Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

NCT00004829 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

FED

Sponsor class

Conditions

Cystic Fibrosis
Bacterial Infection

Interventions

DRUG: tobramycin

Sponsor

FDA Office of Orphan Products Development